Group Psychotherapy for Loneliness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help older adults who feel lonely and have a psychiatric disorder. Researchers seek to determine if group therapy focused on building awareness, courage, and love can reduce loneliness. Participants will either join the therapy group or remain on a waitlist as a control group. This trial suits older adults with a psychiatric disorder who can engage in group activities. As an unphased trial, it offers a unique opportunity for participants to explore innovative therapy methods that could enhance their well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this group psychotherapy is safe for older adults?
Research shows that the Awareness, Courage, and Love (ACL) group therapy is generally safe for patients. Previous studies on similar therapies have not reported any serious side effects, indicating that participants usually do not experience harmful effects. Although the current trial does not provide specific safety details, its advanced phase suggests confidence in its safety for participants.
Overall, evidence suggests that ACL group therapy is a safe option for reducing loneliness in older adults.12345Why are researchers excited about this trial?
Researchers are excited about Group Psychotherapy for Loneliness because it targets feelings of loneliness through a unique approach called Awareness, Courage, and Love Group Psychotherapy. Unlike typical treatments for loneliness, which often involve medication or individual therapy, this method focuses on group dynamics to foster social connections and emotional resilience. This therapy encourages participants to build awareness of their emotions, develop the courage to express themselves, and cultivate love and empathy within a group setting, which can lead to more meaningful and supportive relationships. This innovative approach could offer a powerful alternative for those who feel isolated, providing them with tools to connect with others more deeply.
What evidence suggests that Awareness, Courage, and Love Group Psychotherapy is effective for loneliness?
Research has shown that the Awareness, Courage, and Love (ACL) Group Therapy, which participants in this trial may receive, can enhance social connections and improve well-being. Early findings suggest that group members feel less lonely and more connected to others. One study on online ACL groups found that participants experienced stronger social ties and greater satisfaction. These groups use conversations and activities to foster closer relationships and provide emotional support. Although more research is needed, the early results are promising for those who feel lonely.12356
Who Is on the Research Team?
Serena Wong, Ph.D.
Principal Investigator
St. Joseph's Health Care London
Are You a Good Fit for This Trial?
This trial is for older adults who are experiencing loneliness and have psychiatric disorders. It aims to test a group therapy intervention specifically designed for geriatric psychiatry outpatients.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive group psychotherapy intervention called Awareness, Courage, and Love Groups
Follow-up
Participants are monitored for feasibility and acceptability of the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Awareness, Courage, and Love Group Psychotherapy
Trial Overview
The study is testing the effectiveness of 'Awareness, Courage, and Love Group Psychotherapy', which is based on functional analytic psychotherapy (FAP) to address loneliness in older adults.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Treatment group receiving psychotherapy
Waitlist control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lawson Health Research Institute
Lead Sponsor
London Health Sciences Centre OR Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
Western University, Canada
Collaborator
Published Research Related to This Trial
Citations
An Awareness, Courage, and Love Online Group ...
This study aims to evaluate an online Awareness, Courage, and Love (ACL) group intervention designed to enhance social connectedness and subjective well-being
Love Group for Geriatric Psychiatry Outpatients
The objective of this clinical trial is to adapt, implement, and evaluate a type of loneliness group intervention called Awareness, Courage, and Love Groups for ...
Study Protocol for a Randomised Controlled Trial
This study aims to evaluate an online Awareness, Courage, and Love (ACL) group intervention designed to enhance social connectedness and ...
Group Psychotherapy for Loneliness · Info for Participants
Trial Overview The study is testing the effectiveness of 'Awareness, Courage, and Love Group Psychotherapy', which is based on functional analytic psychotherapy ...
A geriatric psychiatry inpatient pilot intervention for loneliness
Inpatient psychiatry units are ideally suited for piloting a novel intervention for loneliness that is based on Awareness, Courage, and Love (ACL) groups.
Group Intervention for Loneliness · Info for Participants
The goal of this pilot study is to determine the feasibility and acceptability of a group loneliness intervention in geriatric psychiatry inpatients.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.